Post by
terr2 on Oct 04, 2015 10:08am
Excelent Outlook
Telesta Opportunity Under the radar Canadian public company Led by new management team who have executed transformative change Fully funded business plan $28.6 million US private placement closed August 19th Focused on a near-commercial specialty pharma product MCNA BLA designated for Priority Review by the FDA with a PDUFA date of February 27, 2016 Significant dialogue with US FDA to minimize regulatory risk Perfect specialty product profile Commercial opportunity validated by extensive partnering interest, strong U.S. institutional due diligence and 3rd party market assessment Building a targeted U.S. commercial infrastructure
Comment by
terr2 on Oct 04, 2015 10:37am
Does that sound like speculation to you??? No, this is a certainty ladies an gent's. How they can get away with this manipulation, I don't know. A .34 cent consolidation price is nothing short of CRIMINAL. JMO
Comment by
blartar on Oct 04, 2015 11:49am
YOUR RIGHT ! So why has no other company put in an offer to buy us out while the share price is so low and before all the good news comes out ? JMHO & GLTAL
Comment by
givmeabrake on Oct 04, 2015 12:25pm
SUPERB Outlook. Stellar performance on the part of management. However, they are still failing in the shareholder communications and media department...WHY is Tejesta STILL as stated "under the radar" . No excuse for that. In order to be ON RADAR you have to TRANSMIT on a regular basis. Question I keep asking; is it due to Ideology or strategy?
Comment by
cutthewabs on Oct 04, 2015 1:08pm
This post has been removed in accordance with Community Policy
Comment by
cheetio on Oct 04, 2015 1:30pm
Telesta Opportunity .....Led by a new management team who want shareholders to issue a share consolidation blank cheque.... up to... 1 -15...........geez ..I...missed the recording date....DAMM